tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1
Germany Market

Vertex Pharmaceuticals (VX1) Technical Analysis

Compare
23 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Vertex Pharmaceuticals’s (VX1) Moving Averages Convergence Divergence (MACD) indicator is 2.48, suggesting Vertex Pharmaceuticals is a Buy.
Vertex Pharmaceuticals’s (VX1) 20-Day exponential moving average is 395.43, while Vertex Pharmaceuticals’s (VX1) share price is €394.6, making it a Sell.
Vertex Pharmaceuticals’s (VX1) 50-Day exponential moving average is 388.85, while Vertex Pharmaceuticals’s (VX1) share price is €394.6, making it a Buy.

Vertex Pharmaceuticals (VX1) Pivot Points

Feb 12, 2026, 03:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
385.33
389.87
393.63
398.17
401.93
406.47
410.23
Fibonacci
389.87
393.04
395.00
398.17
401.34
403.30
406.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vertex Pharmaceuticals (VX1) Moving Averages

Feb 12, 2026, 03:57 PM
Period
Simple
Exponential
MA5
398.11Sell
396.98Sell
MA10
398.16Sell
396.99Sell
MA20
393.25Buy
395.43Sell
MA50
390.14Buy
388.85Buy
MA100
373.47Buy
382.35Buy
MA200
373.95Buy
390.09Buy
Vertex Pharmaceuticals’s (VX1) 10-Day exponential moving average is 396.99, while Vertex Pharmaceuticals’s (VX1) share price is €394.6, making it a Sell.
Vertex Pharmaceuticals’s (VX1) 100-Day exponential moving average is 382.35, while Vertex Pharmaceuticals’s (VX1) share price is €394.6, making it a Buy.
Vertex Pharmaceuticals’s (VX1) stock price is €394.6 and Vertex Pharmaceuticals’s (VX1) 50-day simple moving average is 390.14, creating a Buy signal.
Vertex Pharmaceuticals’s (VX1) stock price is €394.6 and Vertex Pharmaceuticals’s (VX1) 100-day simple moving average is 373.47, creating a Buy signal.
Vertex Pharmaceuticals’s (VX1) stock price is €394.6 and Vertex Pharmaceuticals’s (VX1) 200-day simple moving average is 373.95, creating a Buy signal.

Vertex Pharmaceuticals (VX1) Technical Indicators

Feb 12, 2026, 03:57 PM
Name
Value
Implied Action
RSI (14)
50.48
Neutral
STOCH (9,6)
54.71
Neutral
STOCHRSI (14)
67.17
Neutral
MACD (12,26)
2.48
Buy
ADX (14)
9.80
Buy
Williams %R
-63.79
Buy
CCI (14)
11.40
Neutral
ATR (14)
7.70
-
Ultimate Oscillator
59.02
Neutral
ROC
4.34
Buy
Vertex Pharmaceuticals’s (VX1) Relative Strength Index (RSI) is 50.48, creating a Neutral signal.
Vertex Pharmaceuticals’s (VX1) Trend Strength Indicator (ADX) is 9.80, creating a Buy signal.
Vertex Pharmaceuticals’s (VX1) Commodity Channel Index (CCI) is 11.40, creating a Neutral signal.
Vertex Pharmaceuticals’s (VX1) Price Rate of Change (ROC) is 4.34, creating a Buy signal.

FAQ

Is VX1 a Buy, Hold, or Sell?
Based on VX1’s technical indicators, VX1 is a Buy.
    What is VX1’s RSI (14)?
    VX1’s RSI (14) is 50.48, which suggests VX1 is a Neutral.
      What is VX1’s MACD?
      VX1’s MACD is 2.48, which suggests VX1 is a Buy.
        What is VX1’s 5-day moving average?
        VX1’s 5-day moving average is 398.11, which suggests VX1 is a Sell.
          What is VX1’s 20-day moving average?
          VX1 20-day moving average is 393.25, which suggests VX1 is a Buy.
            What is VX1’s 50-day moving average?
            VX1’s 50-day moving average is 390.14, which suggests VX1 is a Buy.
              What is VX1’s 200-day moving average?
              VX1’s 200-day moving average is 373.95, which suggests VX1 is a Buy.
                What is VX1’s Williams % R (14)?
                VX1’s Williams % R (14) is -63.79, which suggests VX1 is a Buy.
                  What is VX1’s CCI (14)?
                  VX1’s CCI (14) is 11.40, which suggests VX1 is a Neutral.
                    What is the share price of Vertex Pharmaceuticals?